Terms: = Ovarian cancer AND CUX1, ENSG00000160967, P39880, p75, p200, p110, p100, Nbla10317, CUX, COY1, CDP, CASP, 1523 AND Treatment
20 results:
1. Real-World Clinical Outcomes of Ribociclib in Combination with a Non-Steroidal Aromatase Inhibitor and a Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal HR+/HER2- Advanced Breast cancer Patients: An Italian Managed Access Program.
Staropoli N; Geuna E; Rinaldi G; Bisagni G; Scotti V; Faggioni G; Vannini L; Arcara C; Moretti G; Gunnellini M; Coltelli L; Verderame F; Livi L; Sanna G; Grasso D; Abbinante G; Ragni F
Curr Oncol; 2022 Sep; 29(9):6635-6641. PubMed ID: 36135090
[TBL] [Abstract] [Full Text] [Related]
2. Alternative Splicing: A New Therapeutic Target for ovarian cancer.
Yao S; Yuan C; Shi Y; Qi Y; Sridha R; Dai M; Cai H
Technol Cancer Res Treat; 2022; 21():15330338211067911. PubMed ID: 35343831
[No Abstract] [Full Text] [Related]
3. N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of ovarian cancer.
Jiao J; Jiang L; Luo Y
Recent Pat Anticancer Drug Discov; 2021; 16(3):407-416. PubMed ID: 34137363
[TBL] [Abstract] [Full Text] [Related]
4. Effectiveness of Adjuvant ovarian Function Suppression in Premenopausal Women With Early Breast cancer: A Multicenter Cohort Study.
Ferreira AR; Ribeiro J; Miranda A; Mayer A; Passos-Coelho JL; Brito M; Fernandes J; Gouveia J; Costa L; Vaz-Luis I
Clin Breast Cancer; 2019 Oct; 19(5):e654-e667. PubMed ID: 31327728
[TBL] [Abstract] [Full Text] [Related]
5. Increased autophagy in EOC re-ascites cells can inhibit cell death and promote drug resistance.
Liu Y; Tang J; Liu D; Zhang L; He Y; Li J; Gao L; Tang D; Jin X; Kong D
Cell Death Dis; 2018 Apr; 9(4):419. PubMed ID: 29549251
[TBL] [Abstract] [Full Text] [Related]
6. Metformin and epothilone A treatment up regulate pro-apoptotic PARP-1, casp-3 and H2AX genes and decrease of AKT kinase level to control cell death of human hepatocellular carcinoma and ovary adenocarcinoma cells.
Rogalska A; Bukowska B; Marczak A
Toxicol In Vitro; 2018 Mar; 47():48-62. PubMed ID: 29117515
[TBL] [Abstract] [Full Text] [Related]
7. Induction of galectin-1 by TLR-dependent PI3K activation enhances epithelial-mesenchymal transition of metastatic ovarian cancer cells.
Park GB; Chung YH; Kim D
Oncol Rep; 2017 May; 37(5):3137-3145. PubMed ID: 28350104
[TBL] [Abstract] [Full Text] [Related]
8. Low-dose cisplatin-induced CXCR4 expression promotes proliferation of ovarian cancer stem-like cells.
Chen Y; Wang S; Bu S; Xu M; Lai D
Acta Biochim Biophys Sin (Shanghai); 2016 Mar; 48(3):282-9. PubMed ID: 26819076
[TBL] [Abstract] [Full Text] [Related]
9. Development of PIK-75 nanosuspension formulation with enhanced delivery efficiency and cytotoxicity for targeted anti-cancer therapy.
Talekar M; Ganta S; Amiji M; Jamieson S; Kendall J; Denny WA; Garg S
Int J Pharm; 2013 Jun; 450(1-2):278-89. PubMed ID: 23632263
[TBL] [Abstract] [Full Text] [Related]
10. Targeted inhibition of phosphatidyl inositol-3-kinase p110β, but not p110α, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancers.
Jeong JY; Kim KS; Moon JS; Song JA; Choi SH; Kim KI; Kim TH; An HJ
Apoptosis; 2013 Apr; 18(4):509-20. PubMed ID: 23371322
[TBL] [Abstract] [Full Text] [Related]
11. The efficacy of complex decongestive physiotherapy (cdp) and predictive factors of response to cdp in lower limb lymphedema (LLL) after pelvic cancer treatment.
Liao SF; Li SH; Huang HY
Gynecol Oncol; 2012 Jun; 125(3):712-5. PubMed ID: 22426250
[TBL] [Abstract] [Full Text] [Related]
12. Polymeric tubulysin-peptide nanoparticles with potent antitumor activity.
Schluep T; Gunawan P; Ma L; Jensen GS; Duringer J; Hinton S; Richter W; Hwang J
Clin Cancer Res; 2009 Jan; 15(1):181-9. PubMed ID: 19118045
[TBL] [Abstract] [Full Text] [Related]
13. Metastatic ovarian carcinoma-associated subepidermal blistering disease with autoantibodies to both the p200 dermal antigen and the gamma 2 subunit of laminin 5 showing unusual clinical features.
Mitsuya J; Hara H; Ito K; Ishii N; Hashimoto T; Terui T
Br J Dermatol; 2008 Jun; 158(6):1354-7. PubMed ID: 18294311
[TBL] [Abstract] [Full Text] [Related]
14. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract] [Full Text] [Related]
15. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract] [Full Text] [Related]
16. Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer.
Madhusudan S; Muthuramalingam SR; Braybrooke JP; Wilner S; Kaur K; Han C; Hoare S; Balkwill F; Ganesan TS
J Clin Oncol; 2005 Sep; 23(25):5950-9. PubMed ID: 16135466
[TBL] [Abstract] [Full Text] [Related]
17. Sonographic detection of uterine and ovarian abnormalities in female survivors of Wilms' tumor treated with radiotherapy.
Nussbaum Blask AR; Nicholson HS; Markle BM; Wechsler-Jentzch K; O'Donnell R; Byrne J
AJR Am J Roentgenol; 1999 Mar; 172(3):759-63. PubMed ID: 10063876
[TBL] [Abstract] [Full Text] [Related]
18. Soluble tumor necrosis factor receptors and CA 125 in serum as markers for epithelial ovarian cancer.
Onsrud M; Shabana A; Austgulen R
Tumour Biol; 1996; 17(2):90-6. PubMed ID: 8658018
[TBL] [Abstract] [Full Text] [Related]
19. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.
Izquierdo MA; van der Zee AG; Vermorken JB; van der Valk P; Beliën JA; Giaccone G; Scheffer GL; Flens MJ; Pinedo HM; Kenemans P
J Natl Cancer Inst; 1995 Aug; 87(16):1230-7. PubMed ID: 7563169
[TBL] [Abstract] [Full Text] [Related]
20. Partial structural analysis of concanavalin A binding glycopeptides of large size from human teratocarcinoma-derived cells: cleavage by hydrazinolysis and alkaline borohydride.
Rasilo ML; Renkonen O
Can J Biochem; 1982 Jul; 60(7):749-56. PubMed ID: 7116211
[TBL] [Abstract] [Full Text] [Related]
